Extracellular succinate derived from ectopic milieu drives adhesion and implantation growth of ectopic endometrial stromal cells via the SUCNR1 signal in endometriosis
article
OA: gold
CC0
⤵ 4 in-corpus citations
Abstract
BACKGROUND: As a dual-function metabolite, succinate has emerged in cell function and plays a key signaling role in linking mitochondrial function to other cellular functions. Succinate accumulation in the cytoplasm is commonly associated with hypoxia in the microenvironment and immune cell activation. Extracellular succinate released into the microenvironment is considered an inflammatory alarm that can be sensed by its membrane receptor SUCNR1, which boosts proinflammatory responses and acts akin to classical hormones and cytokines. Succinate plays an important role in the development of inflammatory diseases. Whether succinate facilitates the progression of endometriosis (EMs), characterized by chronic inflammation and peritoneal adhesion, is worth exploring.
OBJECTIVE: We mimicked the ectopic milieu in vitro and in vivo to evaluate the main source and potential role of succinate in endometriosis. We assessed the molecular and functional effects of succinate on macrophages and peritoneal mesothelial cells in peritoneal cavity. The effect of succinate/SUCNR1 signaling on ectopic endometrial stromal cells (ESCs) was further explored in this study.
METHODS: In this study, we used targeted organic acid metabolomics analysis and in vitro assays to assess the potential accumulation of succinate in the peritoneal fluid of EMs patients. We examined its correlation with disease severity, Visual Analogue Scale, and the Endometriosis Fertility Index. Flow cytometry, enzyme linked immunosorbent assay, western blot assay, quantitative real-time PCR, and other molecular biology techniques were used to explore the potential mechanisms.
RESULTS: By mimicking the ectopic milieu, we constructed an in vitro co-culture system and found that M1 polarized macrophages and that the peritoneal mesothelial cell line (HMrSV5) mainly released succinate into their microenvironment and activated the succinate receptor (SUCNR1) signal, which further polarized the macrophages and significantly enhanced the invasive survival of ESCs, and the adhesion to the peritoneum. We further investigated the pathological effects of extracellular succinate in vivo using a xenograft mouse models of endometriosis.
CONCLUSIONS: Succinate-SUCNR1 signaling facilitates the creation of inflammatory cells and plays a vital role in EMs progression and peritoneal adhesion. Our work on the molecular mechanisms underlying succinate accumulation and function will help elucidate the phenotypic mysteries of pain and infertility in EMs. Video Abstract.
My notes (saved in your browser only)
Outcome instruments
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum via openalex
- Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy via openalex
- Endometriosis and Infertility via openalex
- Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis via openalex
- IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis via openalex
- Macrophages inhibit and enhance endometriosis depending on their origin via openalex
- The endometrial immune environment of women with endometriosis via openalex
- The Origin and Pathogenesis of Endometriosis via openalex
- W2298980263 via openalex
- W2522038806 via openalex
- W2525683625 via openalex
- W2788731808 via openalex
- W2796893269 via openalex
- W2883879320 via openalex
- W2886565918 via openalex
- W2894645312 via openalex
- W2906197662 via openalex
- W2957261638 via openalex
- W2965088033 via openalex
- W2965312711 via openalex
- W2983051519 via openalex
- W2999533459 via openalex
- W3006446533 via openalex
- W3167492434 via openalex
- W3171653527 via openalex
- W3181107097 via openalex
- W3184584974 via openalex
- W3202739520 via openalex
- W3205159219 via openalex
- W3213157511 via openalex
- W4225146432 via openalex
- W1488288160 via openalex
- W4383723776 via openalex
- W1823805027 via openalex
- W1969905647 via openalex
- W2015738975 via openalex
- W2041030202 via openalex
- W2089532303 via openalex
- W2097080185 via openalex
- W2135414906 via openalex
Cited by (5)
- Inhibiting CSNK2A Suppresses the Viability, Autophagy, Growth and Motility of Ectopic Endometrial Stromal Cells 2026
- The role of macrophage polarization in the development of endometriosis and the therapeutic potential of its modulation 2025
- Endometriosis and autoimmunity 2025
- Innovative medical technology of succinic acid photophoresis in comorbid patients with adenomyosis 2025
- Metabolomic biomarkers of endometriosis: A systematic review 2024
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-11T06:18:01.049809+00:00
License: CC0
· commercial use OK